MATTES GLENN R. (President and CEO) purchased 80.0% of their position (16K shares) of TFF PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $76.5K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/17/2022ACC: 0001213900-22-027791
DirectorOfficer· President and CEO
Since Oct 2019
+16K
Net shares
Net buyer
$76.5K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
16K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+16K
Price / share
$4.78
Trade value
$76.48K
% of position
80.0%
5/16/2022
20K→36K
Total
Net shares
+16K
Net value
$76.48K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/16/2022 | P · Purchase | +16K | $4.78 | $76.48K | 80.0% | 20K | 36K |
| Total | +16K | $76.48K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned7K
Total
7K indirect7K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 7K | Indirect |
| Total | 7K | 7K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported